Search Results - "Sulgey, Gauthami"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
  2. 2

    Nonreciprocity in CHIKV and MAYV Vaccine-Elicited Protection by Weber, Whitney C, Andoh, Takeshi F, Kreklywich, Craig N, Streblow, Zachary J, Denton, Michael, Streblow, Magdalene M, Powers, John M, Sulgey, Gauthami, Medica, Samuel, Dmitriev, Igor, Curiel, David T, Haese, Nicole N, Streblow, Daniel N

    Published in Vaccines (Basel) (01-09-2024)
    “…Chikungunya virus (CHIKV) is a pathogenic arthritogenic alphavirus responsible for large-scale human epidemics for which a vaccine was recently approved for…”
    Get full text
    Journal Article
  3. 3

    Antibody Therapy: From Diphtheria to Cancer, COVID-19, and Beyond by Kumar, Deepak, Gauthami, Sulgey, Bayry, Jagadeesh, Kaveri, Srinivas V, Hegde, Nagendra R

    “…The dawn of the 20th century saw the formative years of developments in immunology. In particular, immunochemistry, specifically pertaining to antibodies, was…”
    Get more information
    Journal Article
  4. 4

    Immunogenicity of a Candidate Ebola Hemorrhagic Fever Vaccine in Mice Based on Controlled In Vitro Expression of Ebolavirus Glycoprotein by Kumar, Deepak, Gauthami, Sulgey, Uma, Madala, Nagalekshmi, Karthika, Rao, Pavuluri Panduranga, Basu, Atanu, Ella, Krishna M, Hegde, Nagendra R

    Published in Viral immunology (01-09-2018)
    “…Ebolavirus (EBOV) is the etiology of Ebola hemorrhagic fever (EHF). A major EHF outbreak in 2014-2015 in West Africa claimed >11,000 lives. A licensed vaccine…”
    Get more information
    Journal Article